SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-001575
Filing Date
2013-01-09
Accepted
2013-01-09 17:29:28
Documents
1
Period of Report
2013-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v331729_form4.html 4  
1 OWNERSHIP DOCUMENT v331729_form4.xml 4 13442
  Complete submission text file 0001144204-13-001575.txt   14848
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CASSIA WAY, SUITE 115 HENDERSON NV 89014
Business Address
Rueckert William Dodge (Reporting) CIK: 0001380016 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 13521183